Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Adults, Elderly Subjects

In brief

Multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TD-1439 in healthy adult and elderly subjects

Key facts

Study ID
NCT02954263
Run by
Theravance Biopharma
People needed
40
Starts
2016-11-01
Expected to finish
2017-04-01
Last updated by the study team
2021-01-20

Who can join

Age: 19 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.